Common questions about Креон Микро (FAQ)
Q: Креон Микро это то же самое, что обычный Креон?
A: Kreon Micro and standard Kreon are both Pancreatic Enzyme Replacement Therapies (PERT) and contain the same active enzymes (lipase, protease, amylase) derived from a porcine source. The key difference typically lies in the specific lipase unit strength or dosing of each capsule, which affects how the product is used, especially for infants and children.
Q: В чем разница между Креон Микро и другими препаратами с панкреатином?
A: All approved Pancreatic Enzyme Replacement Therapy (PERT) products contain the same basic porcine-derived enzymes and a protective enteric coating. However, regulatory documents indicate that these products are not considered interchangeable because they vary in enzyme strength, formulation, and delivery methods. Patients are instructed to use them as prescribed, as required by regulatory guidance.
Q: Почему именно Микро, что это значит?
A: The term 'Micro' refers to the unique pharmaceutical form of the medication. The capsule contains many tiny, enteric-coated microspheres. This micro-granulated form is designed to ensure the enzymes mix efficiently with food and travel simultaneously through the stomach into the small intestine, where they are activated.
Q: Действительно ли Микро легче принимать детям?
A: Official administration guidelines note that for patients who cannot swallow the capsule whole, the contents (microspheres) can be mixed with a small amount of soft, acidic food, such as applesauce. This procedure is described in the official instructions as an option for administration to those who cannot swallow the whole capsule.
Q: Что делать, если пропустил прием Креон Микро?
A: If a dose is forgotten, official instructions strictly advise not taking it between meals or snacks. The enzymes must be present when food is consumed. Regulatory instructions state that the next dose should be taken with the next scheduled meal or snack, following the usual prescribed amount.
Q: Через какое время после начала приема должен ощущаться эффект?
A: Clinical trials evaluate efficacy by measuring the body's ability to absorb nutrients, such as fat, after a short period, typically 5–7 days of treatment. While enzymatic function begins immediately, symptomatic improvements like decreased bloating or normalized stool may take several days and vary individually.
Q: Есть ли ограничения по длительности приема Креон Микро?
A: Because this medication is an enzyme replacement for a chronic deficiency, it is generally intended for long-term use. Its action is entirely localized to the digestive tract with no systemic absorption. Clinical studies have assessed its safety and effectiveness for periods up to six months.
Q: Что произойдет, если принять слишком много Креон Микро?
A: Taking excessively high doses of pancrelipase has been linked to elevated uric acid levels in the blood and urine (hyperuricemia and hyperuricosuria). High doses have been linked to hyperuricemia and may also be associated with certain gastrointestinal discomforts.
Q: Можно ли сочетать Креон Микро с витаминами или БАДами?
A: Official documents report no systemic drug interactions since the enzymes are not absorbed into the bloodstream. Because the therapy helps process fats, it can improve the absorption of fat-soluble vitamins (A, D, E, K). No specific regulatory restrictions are noted regarding taking most common supplements.
Q: Что делать, если после приема Креон Микро не видно улучшений?
A: Regulatory instructions indicate that if symptoms of malabsorption continue, the dosage may need adjustment. Changes to the dosage or treatment plan should be reviewed by the specialist who prescribed the treatment. The patient should not stop or change the dosage without professional guidance.
Q: Какие анализы нужно сдать перед началом приема Креон Микро?
A: Official documents do not mandate specific blood tests for all patients before starting this medication. However, regulatory information advises considering monitoring blood uric acid levels in patients who have pre-existing conditions like gout or high uric acid levels, as the medication may potentially raise these concentrations.
Q: Влияет ли прием Креон Микро на вес человека?
A: Clinical studies in patients with Exocrine Pancreatic Insufficiency (EPI) have shown that taking pancrelipase was associated with a statistically significant increase in body weight in some patients during the treatment period. This finding reflects the improved nutrient processing and assimilation enabled by the enzyme replacement.
Q: Может ли Креон Микро помочь при вздутии или тяжести после еды?
A: Clinical studies evaluate how the enzyme therapy affects symptoms of malabsorption, which include abdominal discomfort and bloating. The improved digestion provided by enzyme replacement is intended to reduce symptoms that arise when food is not broken down properly in the digestive tract.
Q: Есть ли исследования, подтверждающие эффективность Креон Микро при муковисцидозе?
A: Yes, official regulatory documents confirm that this drug was studied and demonstrated effectiveness in randomized, placebo-controlled trials. These studies examined patients with Exocrine Pancreatic Insufficiency (EPI) that was caused by Cystic Fibrosis.
Q: Нужно ли менять диету при приеме Креон Микро?
A: Regulatory instructions indicate that the dosage of pancrelipase is highly individualized and may be calculated based on the amount of fat consumed in the diet. Consultation with a specialist can provide guidance on maintaining a balanced diet while on therapy. Fats must be present for the absorption of fat-soluble vitamins.
Q: Можно ли принимать Креон Микро, если нет проблем с поджелудочной железой?
A: The medication is exclusively indicated for the treatment of Exocrine Pancreatic Insufficiency (EPI). It does not have any official indications for use in individuals who have a normally functioning pancreas, as it is a replacement therapy for a specific enzyme deficiency.
Q: Влияет ли Креон Микро на усвоение жиров?
A: Yes, this is the primary goal of the therapy. The medication contains the enzyme lipase, which is essential for the hydrolysis (breakdown) of fats (triglycerides) into smaller molecules. This process is a crucial step for the subsequent absorption of fats into the body.
Q: Можно ли Креон Микро принимать пожилым людям?
A: Official regulatory documents state that the medicine is approved for use in adult patients of all ages. The product information does not include special restrictions or specific warnings related only to the geriatric age group beyond the general cautions applicable to all adults.
Q: Как узнать, что Креон Микро начал действовать?
A: Patients in clinical studies showed measured improvements in the absorption of fats and proteins, alongside a decrease in stool frequency and improved stool consistency. Over time, patients may also see improved nutritional status, such as weight gain, as the body processes food more efficiently.
Q: Можно ли делить капсулу Креон Микро для более точной дозировки?
A: The capsule may be opened as an authorized alternative administration method for those who cannot swallow it whole, and its contents (microspheres) can be mixed with a small amount of soft, acidic food. However, the regulatory documentation advises against crushing or chewing the microspheres themselves or attempting to divide the dose by counting individual granules, as this can destroy the coating and lead to inaccurate dosing.
Q: Какие нежелательные реакции чаще всего встречаются у детей при приеме Креон Микро?
A: The most common adverse reactions reported in children during clinical studies are the same as in adults, mainly gastrointestinal disorders such as abdominal pain, diarrhea, and vomiting. Additionally, there is a known rare risk of fibrosing colonopathy in children with cystic fibrosis receiving high doses.
Q: Какова роль Креон Микро в лечении хронического панкреатита?
A: The medication is indicated for treating Exocrine Pancreatic Insufficiency (EPI), which frequently occurs as a complication or consequence of chronic pancreatitis. It works by replacing the missing digestive enzymes, helping the patient absorb nutrients.
Q: Влияет ли Креон Микро на стул?
A: Yes, one of the primary indicators of its effectiveness is its impact on bowel movements. Clinical studies have shown that pancrelipase therapy leads to improved stool consistency and a reduction in stool frequency in patients with EPI, reflecting better digestion.
Q: Можно ли принимать Креон Микро для профилактики?
A: The medication does not have official indications for preventive use. It is strictly indicated for the treatment of diagnosed Exocrine Pancreatic Insufficiency (EPI), which is a condition involving a measurable deficit of pancreatic enzymes.
Q: Есть ли особые указания для людей с диабетом, принимающих Креон Микро?
A: While not a direct indication, some reported side effects associated with pancrelipase include fluctuations in blood glucose, such as elevated or lowered levels (hyperglycemia or hypoglycemia). Patients who have diabetes and require enzyme therapy are advised to monitor their blood glucose closely.
Q: Есть ли разница в эффективности между Креон Микро и жидкими формами ферментов?
A: Kreon Micro is a solid, delayed-release formulation with an enteric coating that protects the enzymes from stomach acid degradation. Official regulatory documents do not provide comparative data regarding the effectiveness between this solid form and any existing liquid enzyme forms, as liquid enzymes may be subject to degradation in the stomach.
Q: Может ли Креон Микро вызвать изжогу?
A: Heartburn (dyspepsia) is listed as one of the less common adverse reactions associated with pancrelipase therapy. Additionally, if the microspheres are chewed or held in the mouth before swallowing, the immediate release of enzymes can irritate the lining of the mouth or esophagus, which may be felt as a burning sensation.
Q: Есть ли ограничения на вождение автомобиля при приеме Креон Микро?
A: Official product information states that Kreon Micro has no or only minimal influence on a patient's ability to drive vehicles or operate machinery.
Q: Нужно ли прекращать прием Креон Микро, если почувствовал себя лучше?
A: The medicine is a replacement therapy intended for chronic conditions that result in a long-term enzyme deficiency. Regulatory guidance states that changes to the treatment plan, including discontinuing the drug or altering the dosage, must be managed by the specialist who prescribed the therapy.
